We are live on ! Find out more
BF

BOK Financial Portfolio holdings

AUM $6.54B
1-Year Est. Return 25.41%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+25.41%
3 Year Est. Return
+74.09%
5 Year Est. Return
10 Year Est. Return
AUM
$5.5B
AUM Growth
+$257M
Cap. Flow
-$63.5M
Cap. Flow %
-1.16%
Top 10 Hldgs %
24.1%
Holding
965
New
63
Increased
361
Reduced
409
Closed
61

Top Sells

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$40.3M
2
MSFT icon
Microsoft
MSFT
+$9.85M
3
PFE icon
Pfizer
PFE
+$7.93M
4
AAPL icon
Apple
AAPL
+$7.9M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.54M

Sector Composition

Rank Sector Weight
1 Technology 15.5%
2 Healthcare 12.02%
3 Financials 8.44%
4 Consumer Discretionary 7.62%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
376
SPDR Gold Trust
GLD
$133B
$2.15M 0.04%
13,443
+7,041
+110% +$1.18M
GPN icon
377
Global Payments
GPN
$23.8B
$2.15M 0.04%
10,648
-1,736
-14% -$346K
MANH icon
378
Manhattan Associates
MANH
$11.1B
$2.09M 0.04%
17,834
-1,380
-7% -$167K
NULG icon
379
Nuveen ESG Large-Cap Growth ETF
NULG
$2.67B
$2.09M 0.04%
36,018
+3,150
+10% +$182K
LII icon
380
Lennox International
LII
$14.5B
$2.07M 0.04%
6,646
-1,055
-14% -$306K
TDG icon
381
TransDigm Group
TDG
$69.9B
$2.07M 0.04%
3,517
+91
+3% +$53.6K
ATR icon
382
AptarGroup
ATR
$8.54B
$2.05M 0.04%
14,459
-28
-0.2% -$3.86K
RSP icon
383
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
$2.04M 0.04%
14,377
-507
-3% -$68.4K
ACGL icon
384
Arch Capital
ACGL
$34.5B
$2.02M 0.04%
+52,706
New +$1.88M
RETA
385
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.02M 0.04%
+20,220
New +$2.36M
GGG icon
386
Graco
GGG
$13B
$2M 0.04%
27,935
+102
+0.4% +$7.24K
DRE
387
DELISTED
Duke Realty Corp.
DRE
$2M 0.04%
47,695
+285
+0.6% +$11.5K
OKTA icon
388
Okta
OKTA
$24.4B
$1.97M 0.04%
8,944
+4,056
+83% +$1.02M
NBIX icon
389
Neurocrine Biosciences
NBIX
$18.7B
$1.97M 0.04%
20,208
+1,322
+7% +$139K
XRAY icon
390
Dentsply Sirona
XRAY
$2.75B
$1.96M 0.04%
30,713
-1,654
-5% -$95.9K
AAL icon
391
American Airlines Group
AAL
$10.2B
$1.95M 0.04%
+81,707
New +$1.58M
CTRA
392
DELISTED
Coterra Energy
CTRA
$1.93M 0.04%
102,853
-37,274
-27% -$686K
WSO icon
393
Watsco Inc
WSO
$12.8B
$1.93M 0.04%
7,403
+354
+5% +$87.3K
RS icon
394
Reliance Steel & Aluminium
RS
$20.5B
$1.92M 0.04%
12,625
+351
+3% +$47.2K
INGR icon
395
Ingredion
INGR
$6.33B
$1.92M 0.03%
21,291
-207
-1% -$17.7K
WAT icon
396
Waters Corp
WAT
$37.3B
$1.91M 0.03%
6,734
-1,290
-16% -$352K
RRX icon
397
Regal Rexnord
RRX
$13.5B
$1.9M 0.03%
13,338
-115
-0.9% -$15.8K
SHW icon
398
Sherwin-Williams
SHW
$83.7B
$1.9M 0.03%
7,725
-2,649
-26% -$631K
ON icon
399
ON Semiconductor
ON
$32.6B
$1.89M 0.03%
45,379
+374
+0.8% +$14.4K
GE icon
400
GE Aerospace
GE
$368B
$1.87M 0.03%
28,544
-405
-1% -$24.5K

Similar funds

BOK Financial's Q1 2021 Portfolio in Review

As of Q1 2021, BOK Financial held 965 positions worth $5.5B, up 4.9% from $5.24B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

BOK Financial's Q1 2021 filing shows 63 new, 361 increased, 409 reduced and 61 closed positions. Its largest new stake was DraftKings: 70,303 shares worth $4.31M. The largest sale was iShares Russell 1000 ETF, an estimated $40.3M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • BOK Financial's largest Q1 2021 buy was DraftKings: 70,303 shares worth $4.31M.
  • BOK Financial added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $12.1M increase.
  • BOK Financial's biggest Q1 2021 reduction was iShares Russell 1000 ETF, cutting an estimated $40.3M.
  • BOK Financial fully exited Sarepta Therapeutics in Q1 2021, selling an estimated $4.99M.
  • BOK Financial's ten largest holdings make up 24% of its $5.5B portfolio in Q1 2021.
  • BOK Financial opened 63 new positions and closed 61 in Q1 2021.
  • BOK Financial's portfolio value rose 4.9% quarter-over-quarter to $5.5B.

Based on BOK Financial's 13F filing for Q1 2021, filed 21 Apr 2021.